Meeting
2016 Genitourinary Cancers Symposium
A treatment planning comparison of proton therapy and intensity-modulated radiotherapy (IMRT) for prostate cancer using the normal tissue complication probability (NTCP).
Authors
Benjamin Walker Fischer-Valuck
Washington University in St. Louis, Department of Radiation Oncology, St. Louis, MO
Benjamin Walker Fischer-Valuck , Lindsey Olsen , Thomas Mazur , Michael Altman , Beth Bottani , Hiram Alberto Gay , Jeff M. Michalski
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 153)
DOI
10.1200/jco.2016.34.2_suppl.153
Abstract #
153
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Acute patient-reported toxicities after proton therapy or intensity-modulated radiotherapy for prostate cancer.
First Author: Kimberly Gergelis
Poster
2012 ASCO Annual Meeting
Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.
First Author: James B. Yu
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term outcomes of a pilot study on highly hypofractionated intensity-modulated radiation therapy over three weeks for localized prostate cancer.
First Author: Kiyonao Nakamura